Balchem (Balchem) Retained Earnings : $897.5 Mil (As of Dec. 2023)

View and export this data going back to 1986. Start your Free Trial

What is Balchem Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Balchem's retained earnings for the quarter that ended in Dec. 2023 was $897.5 Mil.

Balchem's quarterly retained earnings increased from Jun. 2023 ($867.3 Mil) to Sep. 2023 ($896.4 Mil) and increased from Sep. 2023 ($896.4 Mil) to Dec. 2023 ($897.5 Mil).

Balchem's annual retained earnings increased from Dec. 2021 ($732.1 Mil) to Dec. 2022 ($814.5 Mil) and increased from Dec. 2022 ($814.5 Mil) to Dec. 2023 ($897.5 Mil).

Balchem Retained Earnings Historical Data

The historical data trend for Balchem's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Balchem Retained Earnings Chart

Balchem Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Retained Earnings

Get a 7-Day Free Trial

590.92

656.74

732.14

814.49

897.49

Balchem Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Retained Earnings	Get a 7-Day Free Trial															814.49	837.20	867.31	896.38	897.49

Balchem Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Balchem (NAS:BCPC) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

Balchem (Balchem) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Balchem Corp (NAS:BCPC) » Definitions » Retained Earnings

Comparable Companies

Traded in Other Exchanges

BL9B:Germany BL9B:Germany

Address

5 Paragon Drive, Montvale, NJ, USA, 07645

Website

https://www.balchem.com

Balchem Corp is engaged in the development, manufacture and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, agricultural, and medical sterilization industries. The segments include 1) Human Nutrition and Health segment provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications. 2) Animal Nutrition and Health segment provide nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride. 3) Specialty Products segment includes re-packaging and distributing a number of performance gases and chemicals for various uses, notably ethylene oxide, propylene oxide, and ammonia.

Executives

David B Fischer	director	425 WINTER ROAD, DELAWARE OH 43015
Olivier Rigaud	director	CORBION NV, PIET HEINKADE 127, AMSTERDAM P7 1019 GM
Monica Vicente	director	C/O FRESH DEL MONTE PRODUCE INC., P.O. BOX 149222, CORAL GABLES FL 33114
Michael Robert Sestrick	officer: Chief Technology Officer	52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
Frederic Boned	officer: SVP/GM, Human Nutri. & Health	5 PARAGON DRIVE, MONTVALE NJ 07645
Van Gunsteren Job Leonard	officer: Vice President	52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
Hatsuki Miyata	officer: General Counsel and Secretary	5 PARAGON DRIVE, MONTVALE NJ 07645
Michael Bent Tignor	officer: Chief Human Resources Officer	52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
Jonathan Harrison Griffin	officer: Vice President	52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
Martin Luther Reid	officer: Chief Supply Chain Officer	52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
William A. Backus	officer: Chief Accounting Officer	52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
Kathleen B Fish	director	ONE PROCTER & GAMBLE PLAZA, CINCINNATI OH 45202
James C Hyde	officer: Sr. Vice President	52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
Scott C Mason	officer: Vice President	C/O NOVAMERICAN STEEL INC, 1050 UNIVERSITY AVENUE, NORWOOD MA 02062
Joyce J. Lee	director	C/O ZOETIS INC., 100 CAMPUS DRIVE, FLORHAM PARK NJ 07940